Food and Drug Administration discusses cooperation between Jordan and Algeria in the field of the pharmaceutical industry

PETRA
Dr. Nizar Muhaidat, Director General of the Jordan Food and Drug Administration, discussed during an official working visit to Algeria with an official Jordanian delegation ways to enhance cooperation in the pharmaceutical industry between the two brotherly countries, review the Algerian pharmaceutical market and visit a number of Jordanian pharmaceutical factories. .
The Foundation said in a statement today, Saturday, that the visit comes within the framework of following up the outcomes of the visit of His Majesty King Abdullah II to Algeria, including the possibility of hosting an official delegation representing the Jordanian pharmaceutical industries sector to meet with the Algerian Minister of Pharmaceutical Industries, in order to enhance cooperation in the pharmaceutical field between the two sides.
Muhaidat affirmed the corporation’s keenness to implement the royal directives and follow up on the important results of the royal visit, which constitutes a great opportunity to open broader horizons for partnership and investment between the two countries in the field of the pharmaceutical industry, and is a culmination of the efforts of various stakeholders in this sector.
He pointed out that the pioneering role of the distinguished Jordanian investments in the pharmaceutical industries in Algeria has become a major contributor and partner to the Algerian pharmaceutical industry in the Algerian pharmaceutical market, which reflects the distinguished reputation that the Jordanian pharmaceutical industries have reached with its qualified cadres and distinguished technical and scientific expertise, which made this industry a source of pride and pride for Jordan and a center of pride for Jordan. Confidence in foreign markets.
The Jordanian delegation included the Secretary General of the Jordanian Pharmaceutical Producers Union and the Director General of Dar Al Dawa for Development and Investment.